Live Quote · NASDAQMAZEHealthcare· Biotechnology

Maze Therapeutics, Inc.

$31.37▼ 3.27%($-1.06)
MKT CAP $1.72BNEXT EARNINGS Mar 24, 2027
50%
Bullish
TickerSpark Score
55/100
▌ Mixed
60
Valuation
40
Profitability
10
Growth
84
Health
80
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MAZE research report →

Analyst Price Target
$75.00+139.1% vs. today

Range $75 – $75

Analyst RatingBuy
6 Buy0 Hold0 Sell

Price Chart

-11.81% · this period
$51.84$37.12$22.39Nov 20May 26Nov 20
52-Week Range30% of range
Low
$21.95
Current
$31.37
High
$53.65